June 26, 2020 / 5:09 PM / 7 days ago

BRIEF-Neovasc Announces Positive Interim Results From Reducer-I Study

June 26 (Reuters) - Neovasc Inc:

* NEOVASC ANNOUNCES POSITIVE INTERIM RESULTS FROM REDUCER-I STUDY

* NEOVASC- 70% OF PATIENTS SAW IMPROVEMENT IN SYMPTOMS BY AT LEAST 1 CCS CLASS THAT WAS MAINTAINED THROUGH 3 YRS

* NEOVASC- 34% PATIENTS SAW IMPROVEMENT IN SYMPTOMS BY AT LEAST 2 CCS CLASSES THAT WAS MAINTAINED THROUGH 3 YRS

* NEOVASC - LESS THAN 1% OF PATIENTS EXPERIENCED DEVICE OR PROCEDURE RELATED MAJOR ADVERSE EVENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below